Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts

Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H1079-86. doi: 10.1152/ajpheart.2000.279.3.H1079.

Abstract

Cardiac hypertrophy and function were studied 6 wk after constriction of the thoracic aorta (TAC) in transgenic (TG) mice expressing constitutively active mutant alpha(1B)-adrenergic receptors (ARs) in the heart. Hearts from sham-operated TG animals and nontransgenic littermates (WT) were similar in size, but hearts from TAC/TG mice were larger than those from TAC/WT mice, and atrial natriuretic peptide mRNA expression was also higher. Lung weight was markedly increased in TAC/TG animals, and the incidence of left atrial thrombus formation was significantly higher. Ventricular contractility in anesthetized animals, although it was increased in TAC/WT hearts, was unchanged in TAC/TG hearts, implying cardiac decompensation and progression to failure in TG mice. There was no increase in alpha(1A)-AR mRNA expression in TAC/WT hearts, and expression was significantly reduced in TAC/TG hearts. These findings show that cardiac expression of constitutively actively mutant alpha(1B)-ARs is detrimental in terms of hypertrophy and cardiac function after pressure overload and that increased alpha(1A)-AR mRNA expression is not a feature of the hypertrophic response in this murine model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Aorta, Thoracic / physiology
  • Aorta, Thoracic / surgery
  • Atrial Natriuretic Factor / genetics
  • Atrial Natriuretic Factor / metabolism
  • Binding, Competitive / drug effects
  • Binding, Competitive / genetics
  • Blood Pressure
  • Cardiac Myosins*
  • Cardiomegaly / genetics
  • Cardiomegaly / metabolism*
  • Constriction, Pathologic
  • Down-Regulation / genetics
  • Heart / physiopathology*
  • Lung / pathology
  • Mice
  • Mice, Inbred Strains
  • Mice, Transgenic
  • Myocardium / metabolism*
  • Myosin Light Chains / biosynthesis
  • Organ Size
  • Pressure
  • Promoter Regions, Genetic
  • RNA, Messenger / biosynthesis
  • Radioligand Assay
  • Receptors, Adrenergic, alpha-1 / genetics*
  • Receptors, Adrenergic, alpha-1 / metabolism*
  • Thrombosis / pathology

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic alpha-Antagonists
  • Myosin Light Chains
  • RNA, Messenger
  • Receptors, Adrenergic, alpha-1
  • myosin light chain 2
  • Atrial Natriuretic Factor
  • Cardiac Myosins